vision core values milestones board of directors management profile mergers & acquisitions international operations strategy subsidiaries bell sons & co. druggists ltd. nova pharmaceuticals australasia pty ltd. relonchem limited time cap labs inc. r & d capabilities quality policy corporate social responsibility world wide operations formulation business overview markets usa europe south east asia africa russia & cis latin america manufacturing facilities locations goa southport uk r & d crams out licensing business development investor relations financial results annual reports quarterly reports analysts presentation compliances shareholding pattern pd contact us news press release media gallery industry overview health and illness oncology and critical care the disorders of the mind and nerves neurological disorder mental disorders skin infections and ulcers gastro intestinal disorders gi cough remedies women s health bacterial infections and its treatment careers overview values life at marksans contact us health care in safe hands wellness through research & development bringing good health closer with global presence comprehensive care from otc to prescription drugs uncompromising diligence world class facilities subsidiaries armed with the vision to develop a global pharmaceutical company marksans pharma constantly endeavors to identify key business players with an edge . click here to know more about our successful endeavors . welcome to marksans pharma ltd. marksans pharma ltd. is an indian pharmaceutical company having a global footprint . our strengths lie in research manufacturing and marketing of finished dosage pharmaceutical formulations . more formulation services marksans pharma has state of the art formulation manufacturing units adhering to international standards and regulations . we employ the latest technology automated manufacturing and packing operations and best practices ensuring the highest quality of healthcare . more overview markets manufacturing facilities news proceedings of 22nd agm corporate presentation october 2014 report of the scrutinizer addendum to notice of 22nd annual general meeting archives health & illness oncology and critical care the disorders of the mind and nerves skin infections and ulcers gastro intestinal disorders gi cough remedies view all investor relation financial results compliances shareholding pattern pd contact us more about us company profile from the chairman s desk vision core values milestones board of directors management profile mergers & acquisitions news press release media gallery international operations strategy subsidiaries r & d capabilities quality policy corporate social responsibility world wide operations industry overview formulation business overview markets manufacturing facilities health and illness oncology and critical care the disorders of the mind and nerves skin infections and ulcers gastro intestinal disorders gi cough remedies women s health bacterial infections and its treatment r & d crams out licensing business development investor relations financial results compliances shareholding pattern pd contact us careers overview values life at marksans site map contact us copyright 2013 marksans pharma . web design by image online pvt. ltd. .